211 
Market Cap
Stock Chart
Cochlear - 30 Day Poll
Recent BLOGS About Cochlear Add New
Latest Company News
|
Commonwealth Bank of Australia Acquires Stake In Cochlear Limited
Reuters Key Development - Dec 1, 2011 |
|
Cochlear Limited Announces Holding Interest Of Manning & Napier Advisors, Inc.
Reuters Key Development - Aug 18, 2011 |
|
GN Store Nord A/S's Subsidiary and Cochlear Ltd Enter into Technology Development and License Agreement
Reuters Key Development - Aug 9, 2011 |
|
Cochlear Limited Announces Holding Interest Of The Bank Of New York Mellon Corporation
Reuters Key Development - Jul 27, 2011 |
|
Cochlear Limited Announces Ownership Interest Of Hyperion Asset Management Limited
Reuters Key Development - Mar 16, 2011 |
Website
Videos related to Cochlear
Company Profile
Cochlear Limited (Cochlear) operates in the implantable hearing device industry. Its products include the cochlear implant system, Baha system, freedom accessories, speech processor upgrades and nucleus freedom implant.
Nucleus Freedom is the next generation of Cochlear's technology, including SmartSound 2, which brings clarity to everyday hearing.
Its bone conduction implant, the Baha system, helps people with conductive hearing loss, mixed hearing loss, as well as Single Sided Deafness (SSD). The Company has also introduced Nucleus Freedom speech processor technology to all of its Nucleus implant recipients. Cochlear's Nucleus Freedom implant with Contour Advance electrode and Nucleus Freedom implant with Straight electrode features an electronics platform with a microchip. During the fiscal year ended June 30, 2009, Cochlear acquired Percutis AB, a Swedish company.
Revenue & Earnings:
For the year ending 30th June 2009
- Revenue up 15% to $694.7 million
- Earnings before Interest and Tax (EBIT) up 10% to $183.3 million
- Net Profit after Tax (NPAT) up 13% to $130.5 million
Upcoming Events:
Development of new products Cochlear Nucleus 5 and Cochlear Baha BP100 completed and available for market release